Hairy Cell Leukemia
(HCL; Leukemic Reticuloendotheliosis)
by Amy Scholten, MPH
Hairy cell leukemia (HCL) is a rare, slow-growing blood cancer. It affects white blood cells called B lymphocytes. White blood cells protect the body from infection. HCL cells look hairy. Illness happens when these cells build up in the bone marrow and spleen.
Leukemia starts in the bone marrow where blood cells are made. It happens when certain blood cells divide without control or order. The abnormal cells crowd out the healthy blood cells. This causes many of the symptoms.
The cause of HCL is not clear. It may be linked to changes in a gene.
HCL is more common in men and people over 50 years old.
There may be no symptoms at first. Symptoms of HCL usually develop slowly over time.
They may include:
The doctor will ask about your symptoms and health history. A physical exam will be done.
Tests may be done, such as:
Images may be taken of bodily structures with a CT scan.
The treatment of HCL depends on symptoms. HCL is a slow-growing cancer. Treatment may not be needed at first. As HCL progresses, treatment may include:
There are no current guidelines to prevent HCL.
American Cancer Society
The Leukemia and Lymphoma Society
Canadian Cancer Society
Provincial Health Services Authority
General information about hairy cell leukemia treatment. National Cancer Institute website. Available at: https://www.cancer.gov/types/leukemia/patient/hairy-cell-treatment-pdq. Accessed March 25, 2021.
Hairy cell leukemia. EBSCO DynaMed website. Available at: https://www.dynamed.com/condition/hairy-cell-leukemia. Accessed March 25, 2021.
Hairy cell leukemia. Leukemia & Lymphoma Society website. Available at:
...(Click grey area to select URL)
Accessed March 25, 2021.
Sarvaria A, Topp Z, et al. Current therapy and new directions in the treatment of hairy cell leukemia: a review. JAMA Oncol. 2016;2(1):123-9.
Treating hairy cell leukemia. American Cancer Society website. Available at: https://www.cancer.org/cancer/chronic-lymphocytic-leukemia/treating/hairy-cell-leukemia.html. Accessed March 25, 2021.
Last reviewed January 2021 by EBSCO Medical Review Board Mohei Abouzied, MD, FACP
Last Updated: 3/25/2021
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at email@example.com. Our Health Library Support team will respond to your email request within 2 business days.